Literature DB >> 23383673

Behavioural and psychological management of somatic symptom disorders: an overview.

Mahendra P Sharma1, M Manjula.   

Abstract

The number of patients who seek help at primary and secondary care for somatic symptoms which cannot be explained by any known medical condition is enormous. It has been proposed to rename 'somatoform disorders' in DSM-IV as 'somatic symptom disorders' in DSM-5. This is supposed to include disorders such as somatization disorder, hypochondriasis, undifferentiated somatoform disorder, pain disorder and factitious disorder. The reason for the renaming and grouping is that all these disorders involve presentation of physical symptoms and/or concern about medical illness. In the literature, there is considerable variation adopted with respect to diagnosis and in the approaches adopted for intervention. However, the common feature of these disorders is the chronicity, social dysfunction, occupational difficulties and the increased healthcare use and high level of dissatisfaction for both the clinician and the patient. A number of behavioural and psychological interventions for somatic symptoms have been carried out at primary, secondary and tertiary care settings and recently there have been more attempts to involve the primary care physicians in the psychological interventions. This review aims at giving an overview of the components of the behavioural and other psychological interventions available for addressing medically unexplained somatic symptoms and to present their efficacy.

Entities:  

Mesh:

Year:  2013        PMID: 23383673     DOI: 10.3109/09540261.2012.746649

Source DB:  PubMed          Journal:  Int Rev Psychiatry        ISSN: 0954-0261


  2 in total

1.  Clinical Characteristics and Referral Patterns of Outpatients Visiting a Japanese Psychosomatic Medicine Clinic.

Authors:  Mutsuhiro Nakao; Takeaki Takeuchi
Journal:  Int J Behav Med       Date:  2016-10

2.  "When the pain won't wane it's mainly in the brain".

Authors:  Ron Pawl
Journal:  Surg Neurol Int       Date:  2013-06-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.